Author

M. O'Kane

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

C. Mullan· 2 shared M. Bucholc· 2 shared S. Ashe· 2 shared A. Parton· 1 shared B. O'Hare· 1 shared L. Maguire· 1 shared P. Cavanagh· 1 shared S. Watterson· 1 shared

Activity by Year

2018-2019 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

C. Mullan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Effects of a demand optimization intervention on laboratory test utilization in primary care

M. Bucholc, M. O'Kane, B. O'Hare, C. Mullan, P. Cavanagh, S. Ashe

This study evaluates a demand optimization intervention's impact on laboratory test utilization by GPs, finding mixed effects including reduced profile tests and increased HbA1c and PSA variability.

bioRxiv · Mar 12, 2019 · PreprintPathology

Primary care use of laboratory tests in Northern Ireland Western Health and Social Care Trust: a cross-sectional study

M. Bucholc, M. O'Kane, C. Mullan, S. Ashe, L. Maguire

This study examines variations in laboratory test ordering by GPs in Northern Ireland, finding no significant association with demographic or socioeconomic factors, but noting differences related to practice setting.

bioRxiv · Mar 12, 2019Biochemistry

Computational modelling of atherosclerosis: developing a community resource

A. Parton, V. McGilligan, M. O'Kane, S. Watterson

This paper develops the first open computational model of atherosclerosis, demonstrating its use in identifying multi-drug interventions for plaque regression.

bioRxiv · Jan 30, 2018Physiology